Reboot Pain (tDCS)

Recruiting now · Not applicable

Conditions studied: Chronic Pain

In brief

This study will examine the effectiveness of tDCS (Transcranial Direct Current Stimulation) in reducing chronic pain when used with Emory Healthcare Veterans Program (EHVP)-ABHP (Accelerated Behavioral Health Program) participants as measured by the Pain, Enjoyment of Life and General Activity Scale (PEG).

Key facts

Study ID

NCT07411859

Run by

Emory University

People needed

100

Starts

2026-02-16

Expected to finish

2027-05-01

Last updated by the study team

2026-04-14

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female, 18-89 years old
• Treated on site for ABHP
• Willing to self-administer tDCS and complete the measures
• PEG pain intensity of 4 or more for most of the day at least 3 days per week
• Have an established PCP (Primary Care Provider) or pain management provider

You may not qualify if…

• Implanted pacemaker
• Seizure Disorder
• Pregnancy, if applicable
• Any new onset of the following:
• Balance Problems
• Difficulty walking
• Bladder incontinence
• Bowel incontinence
• Numbness
• Tingling
• Weakness
• Medical contraindications
• Current use of sodium channel blockers
• Lidocaine (OTC/transdermal delivery is ok)
• Mexiletine
• Amitriptyline; other tricyclic antidepressants
• Anti-epileptic medications: phenytoin, carbamazepine, lamotrigine, oxcarbazepine, rufinamide, lacosamide and eslicarbazepine acetate
• Current use of calcium channel blockers
• Current use of N-Methyl-D-aspartate receptor antagonists
• Ketamine
• Dextromethorphan
• Felbamate
• History of brain surgery
• History of brain tumor
• History of seizure disorder

Where it is running

• The Emory Clinic — Atlanta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.